David Ryan Purdue sold $1.2M of AbbVie (ABBV)

Executed Mar 4, disclosed Mar 6, 2 days later.

Value, as filed

$1.2M

5,230 sh × $233.56

Executed

Mar 4

the trade date, as filed

Disclosed

Mar 6

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DP David Ryan Purdue SVP, Controller profile →

David Ryan Purdue (SVP, Controller) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in AbbVie Inc. (ABBV). The largest single filing was $1.2M of ABBV (5,230 sh × $233.56, as filed), executed Mar 4.

The name

ABBV AbbVie Inc. ABBV · Healthcare · 41 filings in 24 months ticker →

Healthcare · AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→